Noemi Horvath

Noemi Horvath is a female medical professional who specializes in treating patients with Multiple Myeloma, a type of cancer that affects the bone marrow. She is also experienced in performing Bone Marrow Transplants, a procedure that can help patients with certain blood disorders.

Noemi Horvath is known for her caring and compassionate approach towards her patients. She uses her expertise to provide the best possible care and treatment options for each individual. Patients trust her because she takes the time to listen to their concerns and explains things in a way that is easy to understand.

To stay updated with the latest medical knowledge and research, Noemi Horvath regularly attends conferences, reads medical journals, and participates in continuing education programs. This helps her stay informed about new treatments and advancements in the field of oncology.

Noemi Horvath works closely with her colleagues and other medical professionals to ensure that patients receive comprehensive care. She values collaboration and believes that teamwork is essential in providing the best outcomes for patients.

Through her dedication and expertise, Noemi Horvath has made a positive impact on many patients' lives. Her work has helped improve the health and well-being of individuals battling cancer, giving them hope and support throughout their treatment journey.

Noemi Horvath has also contributed to the medical field through her research and publications. One of her notable publications is titled "Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment-An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse," published in Clinical lymphoma, myeloma & leukemia. She has also been involved in clinical trials, such as the study on Selinexor, Bortezomib, and Dexamethasone in patients with Relapsed or Refractory Multiple Myeloma.

Overall, Noemi Horvath is a dedicated and skilled medical professional who is committed to providing high-quality care to her patients and advancing the field of oncology through her research and clinical work.